Dr. Bhaskar Purushottam, MD
Cardiology (Cardiovascular Disease Physician)
4150 5th St
Rapid City, SD 57701
Who else practices at this address →
Pennington County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 23
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 671
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
SD license 9505 -
Student in an Organized Health Care Education/Training Program
PA license MT189705
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Monument Health Rapid City Hospital Rapid City, SD
- Monument Health Spearfish Hospital Spearfish, SD
- Campbell County Health Gillette, WY
- Chadron Hospital Chadron, NE
- Gordon Memorial Hospital District Gordon, NE
Medical groups
- Monument Health Rapid City Hospital Inc (564 clinicians)
- Midwest Heart and Vascular Associates (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 671
- Services billed
- 1,544
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 246 | 201 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 132 | 132 |
| Ultrasound of both sides of head and neck blood flow | 87 | 85 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 77 | 77 |
| Ultrasound study of arm and leg arteries | 68 | 66 |
| Review by radiologist of arm or leg artery image | 63 | 54 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 62 | 43 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 60 | 54 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 53 | 53 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 53 | 53 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Cephalexin Other prescribers in Rapid City, SD | 51 |
| Atorvastatin Calcium Other prescribers in Rapid City, SD | 50 |
| Cilostazol Other prescribers in Rapid City, SD | 34 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Rapid City, SD | 30 |
| Warfarin Sodium Other prescribers in Rapid City, SD | 27 |
| Xarelto (rivaroxaban) Other prescribers in Rapid City, SD | 25 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 45 payments worth $8,532 in total to this clinician.
| Penumbra, Inc. | $7,282 |
|---|---|
| Bard Peripheral Vascular, Inc. | $532 |
| Philips North America LLC | $180 |
| Stryker Corporation | $123 |
| Abbott Laboratories | $119 |
| Boston Scientific Corporation | $85.64 |
| Medtronic, Inc. | $72.23 |
| Abiomed | $58.84 |
| Compensation for services other than consulting (speaking, faculty) | $4,500 |
|---|---|
| Travel and Lodging | $2,144 |
| Food and Beverage | $1,888 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Penumbra, Inc. Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) Indigo System · Peripheral Intervention | $4,500 |
| Penumbra, Inc. Feb 22, 2025 | Travel and Lodging Indigo System · Peripheral Intervention · travel to Salt Lake City, UT | $649 |
| Penumbra, Inc. Feb 23, 2025 | Travel and Lodging Indigo System · Peripheral Intervention · travel to Salt Lake City, UT | $629 |
| Penumbra, Inc. Feb 21, 2025 | Travel and Lodging Indigo System · Peripheral Intervention · travel to Salt Lake City, UT | $348 |
| Penumbra, Inc. Feb 21, 2025 | Travel and Lodging Indigo System · Peripheral Intervention · travel to Salt Lake City, UT | $210 |
| Penumbra, Inc. Feb 23, 2025 | Travel and Lodging Indigo System · Peripheral Intervention · travel to Salt Lake City, UT | $210 |
| Penumbra, Inc. Jun 12, 2025 | Travel and Lodging Indigo System · Peripheral Intervention · travel to Salt Lake City, UT | $98.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $579,273 in research payments for these studies, mostly to the institutions running them.
- HPS-4/TIMI 65/ORION-4: A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals Corporation - A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT)
Novartis Pharmaceuticals Corporation - Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Boston Scientific Corporation · Recruiting · NCT04674969
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.